PIMA548048
Adalimumab Chimeric Recombinant Rabbit Monoclonal Antibody (D2E7 (Adalimumab)), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA548048-Each-of-1 | In Stock | ₹ 46,769.50 |
PIMA548048 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,769.50
GST (18%): ₹ 8,418.51
Total Price: ₹ 55,188.01
Antigen
Adalimumab Chimeric
Classification
Recombinant Monoclonal
Concentration
1 mg/mL
Formulation
PBS with 0.02% ProClin 300
Host Species
Rabbit
Purification Method
Affinity chromatography
Regulatory Status
RUO
Target Species
Human, Mouse
Form
Liquid
Applications
ELISA, Immunocytochemistry, Immunohistochemistry, Inhibition Assays
Clone
D2E7 (Adalimumab)
Conjugate
Unconjugated
Gene Alias
D2E7; Humira
Immunogen
This antibody was generated by affinity maturation from the 2SD4 scFv, which in turn was selected on human TNF alpha by guided phage-display technology, using the murine anti-hTNF alpha antibody Mab32 as a template.
Quantity
200 μg
Primary or Secondary
Primary
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Isotype
IgG κ
Related Products
Description
- Specificity: Binds to soluble TNF-alpha, but not to lymphotoxin (TNF beta)
- Adalimumab (Humira) is a humanized monoclonal antibody that is approved by the U.S
- Food and Drug Administration for the treatment of patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, μgcerative colitis, chronic psoriasis, hidradenitis suppurativa, and juvenile idiopathic arthritis
- Adalimumab binds to the TNF alpha (tumor necrosis factor-alpha), and blocks its interaction with TNF alpha receptors, reducing the inflammatory response of autoimmune diseases.